The Accuracy of Transurethral Bladder Resection in Detecting Bladder Cancer Histological Variants and Their Prognostic Value at Radical Cystectomy.

bladder cancer histological variants transurethral resection

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
22 Jan 2022
Historique:
received: 25 11 2021
revised: 30 12 2021
accepted: 18 01 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 16 2 2022
Statut: epublish

Résumé

to investigate the accuracy of transurethral resection of bladder tumours (TURBT) in detecting histological variants (BHV) at radical cystectomy (RC) and to evaluate the impact of TURBT before cystectomy on oncological outcomes. Data of 410 consecutive RCs were assessed. Positive and negative predictive values were used to assess the accuracy of TURBT in detecting BHV. Cohen's Kappa coefficient was used to calculate the agreement grade. Logistic regression analysis predicted features based on the presence of BHV at TURBT. Multivariable backward conditional Cox regression analysis was used to estimate oncological outcomes. A total of 73 patients (17.8%) showed BHV at TURBT as compared to 108 (26.3%) at RC. A moderate agreement in histological diagnosis was found between TURBT and RC (0.58). However, sensitivity and specificity in detecting BHV were 56% and 96%, respectively. Furthermore, positive predictive value (PPV) was 84.7% and negative predictive value (NPV) was 84.6%. Presence of BHV at TURBT was an independent predictor for pathologic upstage, albeit not a predictor for positive nodes or positive surgical margins. However, at multivariable analysis adjusted for all confounders, presence of BHV at TURBT was an independent predictor for recurrence after RC, but not for survival. Conversely, the presence of BHV at RC was an independent predictor for both recurrence and survival. There was a moderate agreement between TURBT and RC histopathological findings. TURBT, alone, could not provide an accurate and definitive histological diagnosis. Detection of BHV in TURBT specimens is not an independent predictor of oncological outcomes; indeed, only pathological features at RC are associated with worse survival. However, BHV presence in cystectomy specimens resulted as an independent predictor of both cancer-specific and overall mortality.

Identifiants

pubmed: 35160003
pii: jcm11030550
doi: 10.3390/jcm11030550
pmc: PMC8836972
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur Urol. 2019 Nov;76(5):639-657
pubmed: 31443960
Mod Pathol. 2009 Jun;22 Suppl 2:S96-S118
pubmed: 19494856
J Urol. 2010 Jun;183(6):2165-70
pubmed: 20399473
Urology. 2014 Nov;84(5):1141-6
pubmed: 25239253
Can Urol Assoc J. 2009 Dec;3(6 Suppl 4):S193-8
pubmed: 20019984
Urol Oncol. 2017 Aug;35(8):528.e1-528.e5
pubmed: 28433471
J Clin Oncol. 2005 Sep 20;23(27):6533-9
pubmed: 16116151
World J Urol. 2018 Feb;36(2):231-240
pubmed: 29127452
Histopathology. 2009 Jun;54(7):885-900
pubmed: 19178589
Eur Urol. 2020 Apr;77(4):439-446
pubmed: 31708296
Eur Urol. 2018 Apr;73(4):560-569
pubmed: 29325693
Urology. 2007 Jul;70(1):69-74
pubmed: 17656211
Urol Oncol. 2013 Nov;31(8):1650-5
pubmed: 22608543
Eur Urol. 2016 Jul;70(1):106-119
pubmed: 26996659
Int J Surg Pathol. 2005 Apr;13(2):143-53
pubmed: 15864376
Eur Urol Focus. 2020 Jul 15;6(4):653-663
pubmed: 31530497
BMC Urol. 2015 May 30;15:46
pubmed: 26025446
World J Urol. 2021 Jun;39(6):1917-1926
pubmed: 32696127
Minerva Urol Nefrol. 2018 Dec;70(6):594-597
pubmed: 30203936
Cancer. 2017 Nov 15;123(22):4346-4355
pubmed: 28743155
J Urol. 2008 Jul;180(1):121-7
pubmed: 18485392

Auteurs

Giovanni La Croce (G)

Department of Urology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.

Richard Naspro (R)

Department of Urology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.

Marco Finati (M)

Department of Urology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.

Federico Pellucchi (F)

Department of Urology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.

Mario Sodano (M)

Department of Urology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.

Michele Manica (M)

Department of Urology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.

Michele Catellani (M)

Department of Urology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.

Andrea Gianatti (A)

Department of Pathology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.

Marco Roscigno (M)

Department of Urology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.

Luigi Filippo Da Pozzo (LF)

Department of Urology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
School of Medicine, University of Milano-Bicocca, 20126 Milan, Italy.

Classifications MeSH